 Clovis Oncology, Inc. NASDAQ:CLVS Q2 2022 Earnings Conference Call August 8, 2022 8:30 AM ET Company Participants Anna Sussman - VP, IR Patrick Mahaffy - Co-Founder, CEO, President Executive Director Lindsey Rolfe - EVP, Clinical Development Pharmacovigilance and Chief Medical Officer Daniel Muehl - EVP CFO Conference Call Participants Operator Good morning. My name is Samantha, and I will be your conference operator today. 